The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Human Immunodeficiency Virus (HIV) Diagnosis Market Projected To Reach By 2030?
The market for human immunodeficiency virus (HIV) diagnosis has seen rapid expansion in recent years. This market is anticipated to increase from $4.67 billion in 2025 to $5.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.0%. Historically, this growth can be ascribed to the global prevalence of HIV infections, government-driven HIV screening initiatives, enhanced availability of rapid diagnostic kits, the expansion of diagnostic laboratory infrastructure, and increasing public health awareness campaigns.
The human immunodeficiency virus (hiv) diagnosis market size is predicted to demonstrate significant expansion in the upcoming years. It is projected to reach $7.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This anticipated growth during the forecast period stems from factors such as increasing demand for early hiv detection, wider acceptance of self-test kits, the proliferation of point-of-care diagnostic technologies, an escalating emphasis on hiv prevention and monitoring, and growing investments within infectious disease diagnostics. Prominent trends for the forecast period include a rise in the adoption of rapid and point-of-care hiv testing, an intensified focus on early and routine hiv screening, surging demand for self-testing and home-based diagnostics, the expansion of integrated hiv testing and counseling services, and an increased concentration on data-driven hiv surveillance and reporting.
Access Your Free Sample Report For In-Depth Market Analysis:
What Leading Drivers Are Supporting The Human Immunodeficiency Virus (HIV) Diagnosis Market Expansion?
An anticipated increase in blood donation is set to fuel the expansion of the HIV diagnosis market. Blood donation involves the voluntary process of donating blood via phlebotomy, a procedure where a needle is placed into a vein to draw blood. This increase in blood donation is a result of progress in medical technology, greater community involvement, and enhanced strategies for recruiting and retaining donors. As more individuals donate blood, a larger collection of samples becomes accessible for HIV testing. The expanded availability of blood samples enables more thorough screening for HIV antibodies or antigens, thereby enhancing the precision and dependability of HIV diagnosis. For example, NHS Blood and Transplant, a governmental body in the UK, saw an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Consequently, the growing rate of blood donation is contributing to the growth of the HIV diagnosis market.
How Is Segmentation Applied In The Human Immunodeficiency Virus (HIV) Diagnosis Market Segment Analysis?
The human immunodeficiency virus (hiv) diagnosis market covered in this report is segmented –
1) By Product: Consumables, Instruments, Software, Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing
What Emerging Trends Are Seen In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Companies operating in the human immunodeficiency virus (HIV) diagnosis market are prioritizing the development of highly effective, long-acting prevention and treatment options, increasing access through supportive reimbursement programs, and advancing innovative clinical strategies to improve adherence and reduce new HIV infections. For example, in June 2025, Gilead Sciences, a US-based healthcare company, obtained FDA approval for Yeztugo (lenacapavir), representing the first and only twice-yearly injectable PrEP option, marking a significant advancement in HIV prevention. Supported by Phase 3 PURPOSE 1 and PURPOSE 2 data, the drug exhibited exceptional efficacy, with =99.9% of participants remaining HIV-negative. This long-acting injection is designed to overcome barriers such as adherence challenges, stigma, and low awareness that currently limit PrEP use. Yeztugo’s approval provides a promising tool to aid in reducing new HIV infections across diverse populations. Gilead is also implementing comprehensive access measures, including insurance partnerships, co-pay assistance for eligible patients, and free access for uninsured individuals through specific assistance programs.
Who Are The Companies Participating In The Human Immunodeficiency Virus (HIV) Diagnosis Market Environment?
Major companies operating in the human immunodeficiency virus (hiv) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Molecular Diagnostics, Atila BioSystems Inc.
Get The Full Human Immunodeficiency Virus (HIV) Diagnosis Market Report:
Which Region Has The Greatest Market Share In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
North America was the largest region in the HIV diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (hiv) diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Human Immunodeficiency Virus (HIV) Diagnosis Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Human Immunodeficiency Virus (HIV) Diagnosis Market 2026, By The Business Research Company
Autoimmune Disease Diagnosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Infectious Disease Diagnostics Testing Market Report 2026
Syphilis Immunoassay Diagnostics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
